Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Garth C Wright

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Therapeutic Advances in Cardiovascular Disease|December 22, 2017
Retrospective review of the use of as-needed hydralazine and labetalol for the treatment of acute hypertension in hospitalized medicine patientsMichelle F Gaynor, Garth C Wright, Sheryl Vondracek
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 8, 2020
Comparison of two different intravenous serotonin antagonists used for chemotherapy-induced nausea and vomiting prophylaxis in patients treated with moderately emetogenic risk regimens: A retrospective analysis from a large academic medical centerMelissa Gamble, Elisabeth Carroll, Garth C Wright, et al.
Critical Care Medicine|January 20, 2023
The authors replyGretchen L Sacha, Tyree H Kiser, Garth C Wright, et al.
Journal of Thrombosis and Thrombolysis|June 10, 2022
Evaluation of safety and efficacy outcomes of direct oral anticoagulants versus warfarin in normal and extreme body weights for the treatment of atrial fibrillation or venous thromboembolismAlison R Novak, Courtney Shakowski, Toby C Trujillo, et al.
Pharmacoeconomics|February 21, 2025
Innovative Payment Models for Sickle-Cell Disease Gene Therapies in Medicaid: Leveraging Real-World Data and Insights from CMMI's Gene Therapy Access ModelAntal Zemplenyi, Jim Leonard, Garth C Wright, et al.
Pharmacoeconomics|November 22, 2023
Using Real-World Data to Inform Value-Based Contracts for Cell and Gene Therapies in MedicaidAntal Zemplenyi, Jim Leonard, Michael J DiStefano, et al.
Critical Care Medicine|October 4, 2021
Association Between Vasopressin Rebranding and Utilization in Patients With Septic ShockGretchen L Sacha, Tyree H Kiser, Garth C Wright, et al.
Pharmacotherapy|December 29, 2018
Evaluation of Prophylactic Heparin Dosage Strategies and Risk Factors for Venous Thromboembolism in the Critically Ill PatientPaul M Reynolds, Edward T Van Matre, Garth C Wright, et al.
Annals of the American Thoracic Society|March 31, 2023
Association between Substance Misuse and Outcomes in Critically III Patients with PneumoniaPaul M Reynolds, Majid Afshar, Garth C Wright, et al.
Journal of Medical Internet Research|August 12, 2025
Frequency and Predictors of Virtual Visits in Patients With Heart Failure Within a Large Health System: Retrospective Cohort StudyAnna M Maw, Garth C Wright, Meagan R Bean, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Therapeutic Advances in Cardiovascular Disease|December 22, 2017
Retrospective review of the use of as-needed hydralazine and labetalol for the treatment of acute hypertension in hospitalized medicine patientsMichelle F Gaynor, Garth C Wright, Sheryl Vondracek
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 8, 2020
Comparison of two different intravenous serotonin antagonists used for chemotherapy-induced nausea and vomiting prophylaxis in patients treated with moderately emetogenic risk regimens: A retrospective analysis from a large academic medical centerMelissa Gamble, Elisabeth Carroll, Garth C Wright, et al.
Critical Care Medicine|January 20, 2023
The authors replyGretchen L Sacha, Tyree H Kiser, Garth C Wright, et al.
Journal of Thrombosis and Thrombolysis|June 10, 2022
Evaluation of safety and efficacy outcomes of direct oral anticoagulants versus warfarin in normal and extreme body weights for the treatment of atrial fibrillation or venous thromboembolismAlison R Novak, Courtney Shakowski, Toby C Trujillo, et al.
Pharmacoeconomics|February 21, 2025
Innovative Payment Models for Sickle-Cell Disease Gene Therapies in Medicaid: Leveraging Real-World Data and Insights from CMMI's Gene Therapy Access ModelAntal Zemplenyi, Jim Leonard, Garth C Wright, et al.
Pharmacoeconomics|November 22, 2023
Using Real-World Data to Inform Value-Based Contracts for Cell and Gene Therapies in MedicaidAntal Zemplenyi, Jim Leonard, Michael J DiStefano, et al.
Critical Care Medicine|October 4, 2021
Association Between Vasopressin Rebranding and Utilization in Patients With Septic ShockGretchen L Sacha, Tyree H Kiser, Garth C Wright, et al.
Pharmacotherapy|December 29, 2018
Evaluation of Prophylactic Heparin Dosage Strategies and Risk Factors for Venous Thromboembolism in the Critically Ill PatientPaul M Reynolds, Edward T Van Matre, Garth C Wright, et al.
Annals of the American Thoracic Society|March 31, 2023
Association between Substance Misuse and Outcomes in Critically III Patients with PneumoniaPaul M Reynolds, Majid Afshar, Garth C Wright, et al.
Journal of Medical Internet Research|August 12, 2025
Frequency and Predictors of Virtual Visits in Patients With Heart Failure Within a Large Health System: Retrospective Cohort StudyAnna M Maw, Garth C Wright, Meagan R Bean, et al.
Pageof 1